3,3,4,4,4-Pentafluorobutyl Iodide Manufacturing Process Scale-Up: From Lab to Industrial Production
- Industrial-scale synthesis of 1,1,1,2,2-Pentafluoro-4-iodobutane leverages catalytic telomerization with precise control over HF/ICl ratios and antimony-based Lewis acids to achieve >90% reaction yields.
- Consistent industrial purity (>98%) requires rigorous work-up protocols—water washing, caustic scrubbing, drying, and fractional distillation—to remove HCl, residual HF, and byproducts like diiodo impurities.
- NINGBO INNO PHARMCHEM CO.,LTD. offers bulk price advantages and full COA documentation for this fluorinated intermediate, supporting pharmaceutical R&D and specialty chemical applications globally.
The scale-up of 3,3,4,4,4-Pentafluorobutyl Iodide (also known as 1,1,1,2,2-Pentafluoro-4-iodobutane, CAS 40723-80-6) from laboratory curiosity to commercially viable fluorinated intermediate demands meticulous attention to reaction engineering, material compatibility, and purification logistics. As a key building block in fluorochemical synthesis—particularly for telomerization processes and advanced pharmaceutical intermediates—its industrial production must balance high yield, stringent purity, and cost-effective bulk manufacturing. This article details the technical nuances of scaling its manufacturing process, emphasizing reproducibility, safety, and commercial readiness.
Synthesis Route: Catalytic Telomerization Under Controlled Fluorination
The most industrially robust synthesis route for 1,1,1,2,2-Pentafluoro-4-iodobutane builds upon established methodologies for perfluoroalkyl iodides, adapted for C4 chain length. The core reaction involves the telomerization of tetrafluoroethylene (TFE) or hexafluoropropylene derivatives using iodine monochloride (ICl) and anhydrous hydrogen fluoride (HF) in the presence of a Lewis acid catalyst.
Key reagents include:
- Olefin precursor: Typically derived from perfluorobutene isomers or via controlled oligomerization.
- Iodinating agent: ICl (often generated in situ from I₂ + Cl₂) ensures regioselective iodo-fluorination.
- Fluorination medium: Excess anhydrous HF acts as both solvent and fluorine source.
- Catalyst: Antimony pentachloride (SbCl₅) or antimony pentafluoride (SbF₅) at 5–20 mol% relative to olefin.
Reaction conditions are tightly controlled: - Temperature: 70–170°C - Pressure: 10–60 atm (autogenous, driven by HF vapor pressure) - Molar ratios: HF (5–20 eq), ICl (0.8–1.2 eq), catalyst (0.05–0.2 eq)
Under optimized parameters, this route achieves conversion rates exceeding 95%, with isolated yields of 1,1,1,2,2-Pentafluoro-4-iodobutane typically ranging from 85% to 92%. Side products—such as diiodo adducts or chlorinated analogs—are minimized through precise stoichiometry and catalyst selection.
Process Scale-Up: Engineering Considerations for Bulk Production
Transitioning from gram-scale lab synthesis to multi-hundred-kilogram batches introduces significant engineering challenges:
Material Compatibility and Reactor Design
Anhydrous HF and halogenated intermediates are highly corrosive above 100°C. Industrial reactors must be constructed from nickel alloys (e.g., Hastelloy) or chromium-molybdenum steel to withstand prolonged exposure. Agitation systems require magnetic or mechanical seals rated for high-pressure, high-temperature fluorination environments.
Thermal and Pressure Management
The exothermic nature of HF addition necessitates staged reagent dosing and robust cooling capacity. Pressure relief systems must accommodate rapid gas evolution (HCl, unreacted HF) during quenching. Continuous or semi-batch modes are preferred for large-scale runs to enhance heat/mass transfer and reduce hot-spot formation.
Work-Up and Purification Protocol
Post-reaction isolation is critical for achieving pharma-grade industrial purity. The standard sequence includes: 1. Controlled depressurization and off-gassing into scrubber trains. 2. Water washing to remove HF and water-soluble salts. 3. Caustic wash (5–15% NaOH) to neutralize residual acids. 4. Drying over granular CaCl₂ or molecular sieves. 5. Fractional distillation under reduced pressure to isolate the target compound (bp ~110–115°C at 760 mmHg).
Gas chromatography (GC) and 19F NMR verify final purity, with commercial batches routinely exceeding 98% assay.
Commercial Supply and Quality Assurance
For B2B buyers requiring reliable, large-volume access, sourcing from an experienced global manufacturer is essential. When sourcing high-purity 1,1,1,2,2-Pentafluoro-4-iodobutane, procurement teams should prioritize suppliers offering full regulatory documentation, including Certificates of Analysis (COA), GHS-compliant SDS, and traceable batch records.
NINGBO INNO PHARMCHEM CO.,LTD. specializes in fluorinated intermediates and provides this compound in bulk quantities (kg to MT scale) with consistent quality, competitive bulk price structures, and rapid global logistics. Their manufacturing facility adheres to ISO 9001 standards, ensuring batch-to-batch reproducibility for pharmaceutical and agrochemical clients.
Comparative Performance: Catalyst Impact on Yield and Purity
The choice of Lewis acid profoundly influences efficiency. Data adapted from industrial process studies illustrate this effect:
| Catalyst (mol%) | Reaction Temp (°C) | Reaction Time (h) | Crude Yield (%) | Final Purity after Distillation (%) |
|---|---|---|---|---|
| SbCl₅ (10%) | 140–150 | 3 | 89 | 98.2 |
| SbF₅ (10%) | 130–140 | 2.5 | 92 | 98.5 |
| BF₃ (5%) | 80–90 | 4 | 78 | 97.0 |
| No catalyst | 165 | 5 | 34 | 85.0 |
As shown, antimony-based catalysts significantly outperform alternatives in both rate and selectivity. NINGBO INNO PHARMCHEM CO.,LTD. employs SbF₅/SbCl₅ hybrid systems to maximize yield while minimizing heavy metal residues, aligning with green chemistry principles.
Conclusion
The industrial-scale manufacturing process for 3,3,4,4,4-Pentafluorobutyl Iodide hinges on catalytic precision, corrosion-resistant engineering, and disciplined purification. With demand rising in fluoro-pharma and electronic materials sectors, reliable supply chains are paramount. NINGBO INNO PHARMCHEM CO.,LTD. stands as a premier global manufacturer, delivering high-industrial purity 1,1,1,2,2-Pentafluoro-4-iodobutane with full COA transparency and scalable production capacity—ensuring your R&D or commercial operations never face supply bottlenecks.